Toxicity assessment of metoprolol and its photodegradation mixtures obtained by using different type of TiO2 catalysts in the mammalian cell lines

Science of the Total Environment

Volumn 463-464, Issue , 2013, Pages 968-974

  Četojević Simin, Dragana D ^a   Armaković, Sanja J ^a   Šojić, Daniela V ^a   Abramović, Biljana F ^a  

^a UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

H 4 II E; HT 29; Metoprolol; MRC 5; Photodegradation; Toxicity

Indexed keywords

DEGRADATION MIXTURES; DIFFERENT MECHANISMS; H-4-II-E; HT-29; METOPROLOL; MRC-5; PHOTO CATALYTIC DEGRADATION; PHOTODEGRADATION PRODUCTS;

CATALYSTS; CELL CULTURE; MIXTURES; PHOTODEGRADATION; TITANIUM DIOXIDE;

TOXICITY;

METOPROLOL; TITANIUM DIOXIDE; TITANIUM DIOXIDE DEGUSSA P25; TITANIUM DIOXIDE WACKHERR; UNCLASSIFIED DRUG;

CATALYSIS; CATALYST; CONCENTRATION (COMPOSITION); IRRADIATION; PHOTODEGRADATION; TOXICITY; TROPHIC LEVEL;

ANIMAL CELL; ARTICLE; BIOASSAY; CELL GROWTH; CELL SPECIFICITY; CELL STRAIN HT29; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FETUS; FETUS LUNG; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS CELL; MAMMAL CELL; MINERALIZATION; NONHUMAN; PHOTOCATALYSIS; PHOTODEGRADATION; PRIORITY JOURNAL; RAT; TOXICITY TESTING; ULTRAVIOLET RADIATION;

H-4-II-E; HT-29; METOPROLOL; MRC-5; PHOTODEGRADATION; TOXICITY;

ALANINE; ANIMALS; BIOLOGICAL ASSAY; CATALYSIS; CELL LINE; CELL LINE, TUMOR; HT29 CELLS; HUMANS; METOPROLOL; PHOTOLYSIS; RATS; TITANIUM; TOXICITY TESTS;

EID: 84880681203     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2013.06.083     Document Type: Article

References (36)

1. 2-based photocatalysts with different surface area. Identification of intermediates and proposal of degradation pathways. J Hazard Mater 2011, 198:123-132.
2. Altenburger R., Nendza M., Schuurmann G. Mixture toxicity and its modelling by quantitative structure-activity relationships. Environ Toxicol Chem 2003, 22:1900-1915.
3. Benner J., Ternes T.A. Ozonation of metoprolol: elucidation of oxidation pathways and major oxidation products. Environ Sci Technol 2009, 43:5472-5480.
4. Berenbaum M.C. The expected effect of a combination of agents: the general solution. J Theoret Biol 1985, 114:413-431.
5. Castano A., Bols N., Braunbeck T., Dierickx P., Halder M., Isomaa B., et al. The use of fish cells in ecotoxicology. ATLA 2003, 31:317-351. (vol. 47).
6. Četojević-Simin D.D., Velićanski S.A., Cvetković D.D., Markov L.S., Mrdanović Z.J., Bogdanović V.V., et al. Bioactivity of Lemon Balm Kombucha. Food Bioprocess Technol 2012, 5:1756-1765.
7. Chen C.Y., Lu C.-L. An analysis of the combined effects of organic toxicants. Sci Total Environ 2002, 289:123-132.
8. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 1999, 107(Suppl. 6):907-938.
9. Dayeh V.R., Schirmer K., Bols N.C. Applying whole-water samples directly to fish cell cultures in order to evaluate the toxicity of industrial effluent. Water Res 2002, 36:3727-3738.
10. Deblonde T., Cossu-Leguille C., Hartemann P. Emerging pollutants in wastewater: a review of the literature. Int J Hyg Environ Health 2011, 214:442-448.
11. Dodd M.C., Kohler H.-P.E., von Gunten U. Oxidation of antibacterial compounds by ozone and hydroxyl radical: elimination of biological activity during aqueous ozonation processes. Environ Sci Technol 2009, 43:2498-2504.
12. Escher B.I., Bramaz N., Richter M., Liener J. Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach. Environ Sci Technol 2006, 40:7402-7408.
13. Halling-Sørensen B., Nors Nielsen S., Lanzky P.F., Ingerslev F., Holten Lützhøft H.C., Jørgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998, 36:357-393.
14. Huang W.-J., Tsai J.-L., Liao M.-H. Cytotoxicity of municipal solid waste incinerator ash wastes toward mammalian kidney cell lines. Chemosphere 2008, 71:1860-1865.
15. Ikehata K., Naghashkar N.J., El-Din M.G. Degradation of aqueous pharmaceuticals by ozonation and advanced oxidation processes: a review. Ozone-Sci Eng 2006, 28:353-414.
16. Khetan S.K., Collins T.J. Human pharmaceuticals in the aquatic environment: a challenge to green chemistry. Chem Rev 2007, 107:2319-2364.
17. Marinšek Logar R., Vodovnik M. The applications of microbes in environmental monitoring. Communicating current research and educational topics in applied microbiology 2007, 577-585. Formatex. A. Méndez-Vilas (Ed.).
18. Munawar M., Munawar I.F., Mayfield C.I., McCarth L.H. Probing ecosystem health: a multi-disciplinary and multi-trophic assay strategy. Hydrobiologia 1989, 188-189:93-115.
19. Neuwoehner J., Fenner K., Escher B.I. Physiological modes of action of fluoxetine and its human metabolites in algae. Environ Sci Technol 2009, 43:6830-6837.
20. Pelaez M., Nolan N.T., Pillai S.C., Seery M.K., Falaras P., Kontos A.G., et al. A review on the visible light active titanium dioxide photocatalysts for environmental applications. Appl Catal B: Environ 2012, 125:331-349.
21. Piram A., Salvador A., Verne C., Herbreteau B., Faure R. Photolysis of β-blockers in environmental waters. Chemosphere 2008, 73:1265-1271.
22. Repetto G., del Peso A., Jos A. Ecotoxicological characterization of complex mixtures. In vitro methods in aquatic toxicology 2003, 295-326. Praxis Publishing Ltd., Chichester, United Kingdom. C. Mothersill, B. Austin (Eds.).
23. Rivas F.J., Beltrán F.J., Encinas A. Removal of emergent contaminants: integration of ozone and photocatalysis. J Environ Manage 2012, 100:10-15.
24. Romero V., De la Cruz N., Dantas R.F., Marco P., Giménez J., Esplugas S. Photocatalytic treatment of metoprolol and propranolol. Catal Today 2011, 161:115-120.
25. Schmitt C.J., Dethloff G.M. Biomonitoring of environmental status and trends (BEST) program: selected methods for monitoring chemical contaminants and their effects in aquatic ecosystems 2000, 81. U.S. Geological Survey, Biological Resources Division, Columbia, ((MO): Information and Technology Report USGS/BRD-2000-0005).
26. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990, 82:1107-1112.
27. 3 hybrid processes: kinetics, reaction mechanism and toxicity. J Hydrol 2012, 472-473:314-327.
28. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 1998, 32:3245-3260.
29. Ternes T.A., Meisenheimer M., McDowell D., Sacher F., Brauch H.-J., Haist-Gulde B., et al. Removal of pharmaceuticals during drinking water treatment. Environ Sci Technol 2002, 36:3855-3863.
30. Tillitt D., Gale R., Meadows J., Zajicek J., Peterman P., Heaton S., et al. Dietary exposure of mink to carp from Saginaw Bay 3. Characterization of dietary exposure to planar halogenated hydrocarbons, dioxin equivalents, and biomagnification. Environ Sci Technol 1996, 30:283-291.
31. 2-assisted photodegradation of pharmaceuticals - a review. Cent Eur J Chem 2012, 10:989-1027.
32. Van den Brandhof E.-J., Montforts M. Fish embryo toxicity of carbamazepine, diclofenac and metoprolol. Ecotoxicol Environ Saf 2010, 73:1862-1866.
33. 2-based heterogeneous photocatalyst. Appl Catal B: Environ 2005, 58:79-88.
34. Wadhia K., Clive Thompson K. Low-cost ecotoxicity testing of environmental samples using microbiotests for potential implementation of the Water Framework Directive. Trends Anal Chem 2007, 26:300-307.
35. Wang L., Xu H., Cooper W.J., Song W. Photochemical fate of beta-blockers in NOM enriched waters. Sci Total Environ 2012, 426:139-145.
36. 2: a case of β-blockers. J Hazard Mater 2010, 179:834-839.